Genomic sequencing specialist Illumina (NASDAQ: ILMN) was something of a victim in the U.S.-China trade spat on Tuesday.

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

China's Ministry of Commerce has put PVH and Illumina on its "unreliable entity" list, and shares of both companies fell ...

As reported by Bloomberg, the country's Ministry of Commerce claimed "that PVH and Illumina infringed the principles of market transactions and undertook damaging actions against Chinese companies." ...

See the 10 stocks » As reported by Bloomberg, the country's Ministry of Commerce claimed "that PVH and Illumina infringed the principles of market transactions and undertook damaging actions ...

The US' PVH (PVH.US) and Illumina (ILMN.US) violated the principle of normal market transactions by interrupting their normal ...

China placed Calvin Klein owner PVH Corp. and US gene sequencing company Illumina Inc. to a so-called blacklist of entities, ...

Shares of genomics company Illumina (NASDAQ:ILMN) fell 8.6% in the morning session after the company reported fourth-quarter results and provided full-year revenue guidance, which fell below Wall ...

San Diego-based gene-sequencing giant Illumina got tangled in the United ... its announcement that the two businesses “violated the principles of normal market transactions, interrupted normal ...

The Ministry of Commerce said PVH and Illumina had “violated normal market transaction principles by unilaterally cutting off normal business dealings with Chinese companies and imposing ...